WNX.AU Wellnex Life Ltd
- Market cap
- AUD 4.82M
- P/E
- -
- P/B
- 0.65x
- ROE
- -147.9%
- Dividend yield
- -
- Fundamental score
- 1.3/5
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is WNX.AU undervalued?
Graham numberThe Graham number of Wellnex Life Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Wellnex Life Ltd fundamental analysis
6 of 21 checks passedROE 0/2
Low return on equity (-147.9%), below 10%.
ROA 0/1
Return on assets (-46.4%) is below the industry median (-3.9%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 1/1
Last year's EPS growth (73.0%) is above the industry median (-27.6%).
Revenue Growth 0/2
Revenue shrank 3.8% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 0/2
High debt to equity (129.9%), above 100%.
Debt Trend 0/1
Debt to equity history is shorter than 5 years.
Cash Runway 2/2
Loss-making but free cash flow is positive.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 1/1
Price to book (0.6x) is below the industry median (1.3x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Wellnex Life Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Wellnex Life Ltd
Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia and New Zealand. It offers topical anti-inflammatory creams, sprays, and roll-ons for the relief of joint and muscle pain under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules un…
Full company profileWellnex Life Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Wellnex Life Ltd annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 928K | 1.44M | 887K | 934K | 1.20M | 18.6M | 27.9M | 16.9M | 23.6M | 24.8M | 47.7M |
| Gross Profit | 157K | 723K | 369K | 447K | -165K | 4.50M | 4.75M | -776K | 6.88M | 2.78M | 4.07M |
| Operating Income | -3.91M | -19.6M | -10.3M | -9.23M | -9.29M | -6.21M | -8.15M | -7.51M | -6.62M | -2.43M | -4.36M |
| EBITDA | -3.92M | -19.8M | -10.2M | -9.23M | -18.4M | -6.35M | -6.82M | -10.6M | -6.62M | -815K | -492K |
| Net Income | -4.15M | -19.8M | -9.91M | -46.3M | -24.7M | -7.45M | -13.8M | -13.7M | -15.6M | -4.55M | -11.0M |
| EPS | -1.39 | -5.10 | -2.42 | -9.67 | -4.09 | -0.92 | -0.81 | -0.81 | -0.53 | -0.14 | -0.15 |
| Balance Sheet | |||||||||||
| Total Assets | 7.88M | 64.4M | 58.4M | 19.2M | 10.4M | 19.6M | 15.0M | 30.9M | 27.8M | 23.8M | 23.8M |
| Total Liabilities | 897K | 2.83M | 6.94M | 16.4M | 10.7M | 15.3M | 14.4M | 24.9M | 16.6M | 16.3M | 16.3M |
| Shareholders' Equity | 6.98M | 61.3M | 51.6M | 25.1M | -249K | 4.36M | 594K | 6.06M | 11.2M | 7.45M | 7.45M |
| Cash & Short-term Investments | 5.82M | 55.8M | 28.1M | 1.14M | 7.78M | 3.18M | 322K | 903K | 497K | 862K | 862K |
| Total Debt | 2.43M | 975K | 2.06M | 5.80M | 9.31M | 7.86M | 6.95M | 10.7M | 5.45M | 9.68M | 9.68M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -3.71M | -6.06M | -12.7M | -7.57M | -4.38M | -8.61M | -6.19M | -6.82M | -666K | -2.81M | 1.33M |
| Capital Expenditure | 32.9K | 770K | 9.69M | 23.8M | 791K | 42.0K | 0.00 | 6.82M | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -3.74M | -6.83M | -22.4M | -31.3M | -5.17M | -8.65M | -6.19M | -6.82M | -666K | -2.81M | 1.33M |
| Ratios | |||||||||||
| ROE | -59.5% | -32.3% | -19.2% | -184.1% | - | -170.9% | -2,331.0% | -226.7% | -138.7% | -61.0% | -147.9% |
| ROA | -52.7% | -30.8% | -17.0% | -240.6% | -236.9% | -38.0% | -92.1% | -44.4% | -56.1% | -19.1% | -46.4% |
| Net Profit Margin | -447.1% | -1,376.3% | -1,117.4% | -4,953.5% | -2,065.9% | -40.0% | -49.6% | -81.1% | -66.0% | -18.3% | -23.1% |
| Debt to Equity | 0.35x | 0.02x | 0.04x | 0.23x | - | 1.80x | 11.70x | 1.76x | 0.48x | 1.30x | 1.30x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Wellnex Life Ltd dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | AUD 10.4M | 0.61 | - |
| 2021 | AUD 9.70M | 1.20 | - |
| 2020 | AUD 1.14M | 0.19 | - |
| 2019 | AUD 3.67M | 0.77 | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:50 on Oct 9, 2024.
Who owns Wellnex Life Ltd
- Insiders 15.96%
- Institutions 7.55%
- Public & others 76.49%
- Shares outstanding 73.0M
- Free float 45.5M
Wellnex Life Ltd company profile
- Company name
- Wellnex Life Ltd
- Ticker
- WNX.AU
- ISIN
- AU0000162281
- Exchange
- Australian Securities Exchange
- Sector
- Consumer Defensive
- Industry
- Food Products
- Fiscal year end
- December
- Address
- Port Park - Building 2, Port Melbourne, VIC, Australia, 3207
- Phone
- 61 3 8399 9419
- Website
- wellnexlife.com.au
About Wellnex Life Ltd
Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia and New Zealand. It offers topical anti-inflammatory creams, sprays, and roll-ons for the relief of joint and muscle pain under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness Life brand; and over-the-counter medicines under the Pharmacy Own brand. The company is also involved in the holding of intellectual properties and trademarks of its products; brand and pharma solution businesses; and investment activities, as well as sales and distribution activities. It exports its products to the United Kingdom and the United Arab Emirates. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Port Melbourne, Australia.
Wellnex Life Ltd management
4- Mr. Eric Jiang B.Com(Hons), BAExecutive Chair
- Mr. Zheng LiCompany Secretary
- Mr. Giuseppe Rinarelli BACC, C.A.Chief Financial Officer
- Nick KroghSales & Marketing Manager